No benefit of factor VII in treatment of ICH: FAST
Although haemostatic therapy with recombinant activated factor VII (rFVIIa) reduced haematoma growth in patients with acute intracerebral haemorrhage, it did not improve survival or functional outcomes, results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial show....
Want to read complete article? Please Sign in or Register.